Search results
Can Eli Lilly ETFs Surge on Approval of Alzheimer's Drug?
Zacks via Yahoo News· 3 weeks agoOn Jun 10, the FDA's Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) voted...
Viridian (VRDN) Up 10% on Clinical Updates for Eye Disease Drug
Zacks via Yahoo News· 1 month agoViridian (VRDN) intends to initiate two late-stage studies on its experimental thyroid eye disease...
Beat the Market Like Zacks: Goldman Sachs, Micron, Amgen in Focus
Zacks via Yahoo News· 1 month agoLast week, our time-tested methodologies served investors well in navigating the market. Check out...
‘Dead wrong’: Lawmakers, advocates decry rejection of MDMA-assisted therapy by FDA panel
The Hill via Yahoo News· 1 month agoA Food and Drug Administration (FDA) panel’s surprising recommendation this week to reject the use...
Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) Now Trades Above Golden Cross: Time to Buy?
Zacks via Yahoo News· 2 months agoAfter reaching an important support level, Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) could be...
Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
Zacks via Yahoo News· 2 months agoAmgen (AMGN) beats first-quarter 2024 estimates for earnings and sales. Amgen is "very encouraged"...
What's in the Cards for Amgen (AMGN) This Earnings Season?
Zacks via Yahoo News· 2 months agoVolume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is...
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Zacks via Yahoo News· 3 months agoWall Street watches a company's quarterly report closely to understand as much as possible about its...
Top Analyst Reports for Novartis, American Express & ConocoPhillips
Zacks via Yahoo News· 3 months agoToday's Research Daily features new research reports on 16 major stocks, including Novartis AG...
We Need to be Ready for Biotechnology’s “ChatGPT” Moment
Time via Yahoo News· 3 months agoDoris Cruz works on a sample in the labs of Ring Therapeutics, a biotech company that is conducting...